Dementia
Showing NaN - NaN of 35
Dementia, BPSD Trial in Toronto (Enhanced care transition, Standard care transition)
Terminated
- Dementia
- BPSD
- Enhanced care transition
- Standard care transition
-
Toronto, Ontario, CanadaBaycrest
Sep 20, 2016
Alzheimer's Disease, Dementia Trial in Worldwide (Drug: EVP-6124, Placebo)
Terminated
- Alzheimer's Disease
- Dementia
- Drug: EVP-6124
- Placebo
-
Phoenix, Arizona
- +81 more
May 2, 2016
Dementia, Paratonia Trial in Toronto (Botulinum Toxin, Saline)
Completed
- Dementia
- Paratonia
- Botulinum Toxin
- Saline
-
Toronto, Ontario, CanadaAssistive Technology Clinic at Baycrest
Aug 7, 2014
Mild Cognitive Impairment, Dementia Trial in Toronto (GSK239512)
Completed
- Mild Cognitive Impairment
- Dementia
-
Toronto, Ontario, CanadaGSK Investigational Site
May 31, 2012
Alzheimer's Disease, Dementia Trial in Worldwide (Donepezil HCl)
Completed
- Alzheimer's Disease
- Dementia
- Donepezil hydrochloride
-
Northport, Alabama
- +41 more
Mar 31, 2011
Dementia Trial in Toronto (Far Infrared)
Unknown status
- Dementia
- Far Infrared
-
Toronto, Ontario, CanadaThe Centre for Incurable Diseases
Aug 14, 2009
MDD, Dementia Trial in Toronto (Participants will be screened for depression and cognitive impairment, then receive screening
Unknown status
- Major Depressive Disorder
- Dementia
- Participants will be screened for depression and cognitive impairment, then receive screening results.
-
Toronto, Ontario, CanadaWellness Centre
Feb 7, 2007